| |
|
|
|
Arcus Biosciences Inc.  
|
|
11.23 0.33 (0.03%) |
04-18 16:02 |
|
Open: |
10.88 |
Pre close: |
10.9 |
Target:
|
14.48 
|
|
High: |
11.35 |
Low: |
10.3501 |
Resistance:
|
12.40
13.66
|
|
Volume: |
68,112 |
Market Cap: |
500M |
Support:
|
10.35
8.61
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
11.94
|
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
12.08 |
Signal(12,26,9): |
0.23 |
|
MA(100): |
11.19 |
Stochastic Oscillator |
%K(14,3):
|
25.18 |
|
MA(250): |
12.58 |
%D(3): |
38.55 |
|
Average Volume(K) |
3-Month: |
8861
|
52-Week |
High:
|
17.50 |
|
10-Days: |
7076 |
Low: |
8.57 |
|
RSI |
RSI(14):
|
42.45  |
Change(%): |
-31.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.220 |
Return on Equity (ttm) |
-61.0 |
Shares Out. (M) |
44.53 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-21.3 |
Shares Float (M) |
43.90 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
25.0 |
% Held by Institutions |
50.90 |
|
Forward EPS |
-1.849 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
962 |
|
Book Value (p.s.) |
2.470 |
EBITDA (p.s.) |
0.000 |
P/E |
-5.06 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.55 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-43.00 |
P/S |
2083632768.00 |
|
Operating Margin |
-656.76 |
Levered Free Cash Flow
(M) |
-27.52 |
P/CF |
-11.63 |
|
|
|
|
|
|
